128 related articles for article (PubMed ID: 12007200)
1. Membrane-encased polymer millirods for sustained release of 5-fluorouracil.
Qian F; Nasongkla N; Gao J
J Biomed Mater Res; 2002 Aug; 61(2):203-11. PubMed ID: 12007200
[TBL] [Abstract][Full Text] [Related]
2. Incorporation and in vitro release of doxorubicin in thermally sensitive micelles made from poly(N-isopropylacrylamide-co-N,N-dimethylacrylamide)-b-poly(D,L-lactide-co-glycolide) with varying compositions.
Liu SQ; Tong YW; Yang YY
Biomaterials; 2005 Aug; 26(24):5064-74. PubMed ID: 15769542
[TBL] [Abstract][Full Text] [Related]
3. Development of a novel formulation containing poly(d,l-lactide-co-glycolide) microspheres dispersed in PLGA-PEG-PLGA gel for sustained delivery of ganciclovir.
Duvvuri S; Janoria KG; Mitra AK
J Control Release; 2005 Nov; 108(2-3):282-93. PubMed ID: 16229919
[TBL] [Abstract][Full Text] [Related]
4. Fabrication and characterization of controlled release poly(D,L-lactide-co-glycolide) millirods.
Qian F; Szymanski A; Gao J
J Biomed Mater Res; 2001 Jun; 55(4):512-22. PubMed ID: 11288079
[TBL] [Abstract][Full Text] [Related]
5. Degradation behaviour in vitro for poly(D,L-lactide-co-glycolide) as drug carrier.
Lee JS; Chae GS; Kim MS; Cho SH; Lee HB; Khang G
Biomed Mater Eng; 2004; 14(2):185-92. PubMed ID: 15156109
[TBL] [Abstract][Full Text] [Related]
6. Controlled-release implant system formulated using biodegradable hemostatic gauze as scaffold.
Xu L; Wu F; Yuan W; Jin T
Int J Pharm; 2008 May; 355(1-2):249-58. PubMed ID: 18249510
[TBL] [Abstract][Full Text] [Related]
7. PLGA/mesoporous silica hybrid structure for controlled drug release.
Xue JM; Shi M
J Control Release; 2004 Aug; 98(2):209-17. PubMed ID: 15262413
[TBL] [Abstract][Full Text] [Related]
8. Local release of dexamethasone from polymer millirods effectively prevents fibrosis after radiofrequency ablation.
Blanco E; Weinberg BD; Stowe NT; Anderson JM; Gao J
J Biomed Mater Res A; 2006 Jan; 76(1):174-82. PubMed ID: 16265662
[TBL] [Abstract][Full Text] [Related]
9. Antitumor efficacy and local distribution of doxorubicin via intratumoral delivery from polymer millirods.
Weinberg BD; Ai H; Blanco E; Anderson JM; Gao J
J Biomed Mater Res A; 2007 Apr; 81(1):161-70. PubMed ID: 17120197
[TBL] [Abstract][Full Text] [Related]
10. Thermally sensitive micelles self-assembled from poly(N-isopropylacrylamide-co-N,N-dimethylacrylamide)-b-poly(D,L-lactide-co-glycolide) for controlled delivery of paclitaxel.
Liu SQ; Tong YW; Yang YY
Mol Biosyst; 2005 Jul; 1(2):158-65. PubMed ID: 16880979
[TBL] [Abstract][Full Text] [Related]
11. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method.
Mao S; Shi Y; Li L; Xu J; Schaper A; Kissel T
Eur J Pharm Biopharm; 2008 Feb; 68(2):214-23. PubMed ID: 17651954
[TBL] [Abstract][Full Text] [Related]
12. Nanoporous multilayer poly(L-glutamic acid)/chitosan microcapsules for drug delivery.
Yan S; Rao S; Zhu J; Wang Z; Zhang Y; Duan Y; Chen X; Yin J
Int J Pharm; 2012 May; 427(2):443-51. PubMed ID: 22301425
[TBL] [Abstract][Full Text] [Related]
13. Effects of the type of release medium on drug release from PLGA-based microparticles: experiment and theory.
Faisant N; Akiki J; Siepmann F; Benoit JP; Siepmann J
Int J Pharm; 2006 May; 314(2):189-97. PubMed ID: 16510257
[TBL] [Abstract][Full Text] [Related]
14. Using TEM to couple transient protein distribution and release for PLGA microparticles for potential use as vaccine delivery vehicles.
Zhao A; Rodgers VG
J Control Release; 2006 Jun; 113(1):15-22. PubMed ID: 16707186
[TBL] [Abstract][Full Text] [Related]
15. Water-soluble betamethasone-loaded poly(lactide-co-glycolide) hollow microparticles as a sustained release dosage form.
Chaw CS; Yang YY; Lim IJ; Phan TT
J Microencapsul; 2003; 20(3):349-59. PubMed ID: 12881115
[TBL] [Abstract][Full Text] [Related]
16. Preparation and characterization of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) microspheres for the sustained release of 5-fluorouracil.
Khang G; Kim SW; Cho JC; Rhee JM; Yoon SC; Lee HB
Biomed Mater Eng; 2001; 11(2):89-103. PubMed ID: 11352116
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo evaluation in rabbits of a controlled release 5-fluorouracil subconjunctival implant based on poly(D,L-lactide-co-glycolide).
Wang G; Tucker IG; Roberts MS; Hirst LW
Pharm Res; 1996 Jul; 13(7):1059-64. PubMed ID: 8842045
[TBL] [Abstract][Full Text] [Related]
18. Formulation and investigation of 5-FU nanoparticles with factorial design-based studies.
Bozkir A; Saka OM
Farmaco; 2005 Oct; 60(10):840-6. PubMed ID: 16087183
[TBL] [Abstract][Full Text] [Related]
19. Effect of lactide/glycolide ratio on the in vitro release of ganciclovir and its lipophilic prodrug (GCV-monobutyrate) from PLGA microspheres.
Janoria KG; Mitra AK
Int J Pharm; 2007 Jun; 338(1-2):133-41. PubMed ID: 17363204
[TBL] [Abstract][Full Text] [Related]
20. Development of pH- and time-dependent oral microparticles to optimize budesonide delivery to ileum and colon.
Krishnamachari Y; Madan P; Lin S
Int J Pharm; 2007 Jun; 338(1-2):238-47. PubMed ID: 17368982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
